The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

Novo Nordisk falls as company slashes 2025 forecasts as US sales of Wegovy and Ozempic face headwinds from compounded drugs.

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

Weight loss therapeutics is a lucrative market and one that has now landed Novo Nordisk DKK65.1 billion, or more than US$10 billion, in profits – with nearly half of this from 2024 alone.